Retinoic-Acid-Induced Downregulation of the 67 KDa Laminin Receptor Correlates with Reduced Biological Aggressiveness of Human Neuroblastoma Cells

00 preface_Neuroblastoma - Present and Future......Page 1
Part 1_Neuroblastoma, Clinical Update......Page 11
01 Genetic Factors Influencing the Risk and\rClinical Outcome of Neuroblastoma\r......Page 13
02 Recurrent Neuroblastoma\r......Page 39
Part 2_ Neuroblastoma, Biology Update......Page 63
03 The Cell Biology of Neuroblastoma\r......Page 65
04 Neuroblastoma: A Malignancy Due\rto Cell Differentiation Block\r......Page 89
05 Interplay Between Protein Kinase C\rIsoforms Alpha and Epsilon,\rNeurofibromin, and the Ras/MAPK\rPathway in Neuroblastoma Differentiation\r......Page 95
06 Alternative TrkA Splicing\rand Neuroblastoma\r......Page 121
07 Sympathetic Neurotransmitters\rin Neuroblastoma – Between\rPhysiology and Pathology\r......Page 147
08 Bioactive Sphingolipids in Neuroblastoma\r......Page 163
09 The NBPF Gene Family\r......Page 195
Part 3_ Neuroblastoma, Therapeutic Targets - Present and Future......Page 225
10 Retinoic-Acid-Induced Downregulation\rof the 67 KDa Laminin Receptor Correlates\rwith Reduced Biological Aggressiveness\rof Human Neuroblastoma Cells\r......Page 227
11 The Different Faces\rof Angiogenesis in Neuroblastoma\r......Page 243
12 Application of Molecular Mimicry\rto Target GD2 Ganglioside\r......Page 261
13 MicroRNA Target Signatures in\rAdvanced Stage Neuroblastoma\r......Page 281
14 \rMolecular Chaperones as\rPrognostic Markers of Neuroblastoma......Page 297
15 \rSmall Molecule Drugs and\rTargeted Therapies for Neuroblastoma......Page 309
16 FOXO Transcription Factors as Potential\rTherapeutic Targets in Neuroblastoma\r......Page 335
17 Oncolytic Poliovirus Therapy\rin a Mouse Model of Neuroblastoma:\rPreclinical Data Analysis and Future Studies\r......Page 359